Yesterday I discussed how the “CEO vs Robot” battle between sales and their support teams has lost significance in today’s complex sales environment and ever-changing market dynamics. I stated that innovative technology now makes this polarized framework immaterial. Today, I will expand on my proclamation of how “apps” are triggering this evolution.
Indeed, highly tailored...
Roughly 25 years ago, the pharmaceutical sales representative often played a highly valued role in the day-to-day life of a busy clinician. Pre-internet, physicians at times struggled to remain up to date on the latest research findings or clinical recommendations. The sales representative shared insights about new discoveries and frequently built a bond with physicians, relying during that era on social venues, as well as in-office visits.
The life of a sales representative has changed substantially since that earlier time. Today, sales representatives are more tightly...
Just came back from the 24th annual Academy of Managed Care Pharmacy conference. The two-day event was jam packed with discussion topics ranging from new drug pipelines and comparative effectiveness research, to new developments across government legislation and programs.
There are a series of sessions focused on the growth and development of the specialty drug and pharmacy space. While there is no universal definition of specialty drugs, this class generally refers to complex medications that require more post-prescription utilization management and are often used to treat...
With SCOTUS preparing to take a vote on the individual mandate of the Affordable Care Act (ACA), there is much speculation over what will happen. Many court observers were surprised by the lines of questioning taken by the conservative wing of the court and now have doubts regarding the mandate’s (or the entire bill’s) survival.
There are a couple of interesting angles worth commenting on here. The first one is around court process. Although votes will be taken shortly, these votes are not final until opinions are issued. It is common for...
High Tech Executive Breakfast Briefing May 11, 2012 at 8:00 AM - 2:00 PM Mercedes Benz World
Join Model N for an exclusive Executive Briefing on driving gross-to-net profit and revenue compliance in High Tech-and don't forget driving high-performance cars-on 11 May at Mercedes Benz World. With presentations by Top...
We are experiencing a great response and number of registrations for the 2nd Annual European Pricing Platform (EPP) Pricing and Profit Optimization forum on Life Sciences in Montreux on May 23 and 24. Model N is sponsoring this high-profile, two-day event that addresses the current operational and strategic challenges in the European Life Sciences market.
Various topics will be covered over the two days, looking at adapting commercial strategy, European tender management, rebate, incentives and compliance, a detailed examination of best practice concerning...